Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3888277 | 0.75 | — | — | |
| SCHEMBL5031041 | 0.75 | EPHX1 (0.36) | — | |
| SCHEMBL5551412 | 0.71 | EPHX1 (0.38) | — | |
| SCHEMBL5031068 | 0.70 | CYP19A1 (0.33) | CYP19A1 | |
| SCHEMBL11323027 | 0.70 | — | — | |
| SCHEMBL5551086 | 0.69 | — | — | |
| SCHEMBL9357163 | 0.68 | CYP19A1 (0.35) | CYP19A1 | |
| SCHEMBL20366047 | 0.68 | — | — | |
| SCHEMBL5031013 | 0.68 | NAAA (0.41) | — | |
| Methylamine SCHEMBL2251740 | 0.68 | EPHX1 (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1999167-A2 | ZIEGLER-NATTA CATALYST WITH IN SITU-GENERATED DONOR | Novolen Technology Holdings, C.V. (NL) | 2008-12-10 | — | — | EP | disclosed |
| WO-2007106348-A2 | ZIEGLER-NATTA CATALYST WITH IN SITU-GENERATED DONOR | NOVOLEN TECHNOLOGY HOLDINGS C.V. (NL) | 2007-09-20 | — | — | WO | disclosed |
| US-20070213204-A1 | Ziegler-Natta catalyst with in situ-generated donor | NOVOLEN TECHNOLOGY HOLDINGS C.V. | 2007-09-13 | — | — | US | disclosed |